At Dermama Biotechnology Laboratorium, we are dedicated to advancing regenerative health therapies that transform lives. Our commitment lies in developing cutting-edge, cell-based medical solutions that adhere to the highest global standards, all aimed at enhancing the quality of healthspan for people worldwide.

The biopharmaceutical industry is undergoing rapid growth, driven by innovations such as stem cell therapies, often hailed as “The Future of Medicine.” With the industry generating $163 billion in global revenue—representing 20% of the pharmaceutical market and expanding at a rate of 8% annually—these advancements are reshaping healthcare (McKinsey, 2014).

This momentum underscores the significance of our work at Dermama, where we utilize pioneering stem cell and exosome nanoparticle technologies to tackle age-related and developmental chronic diseases.

By collaborating with top industry leaders and research institutions, we aim to bring innovative therapies to the forefront of modern healthcare. Our goal is to ensure that these advanced treatments are safe, effective and widely accessible, empowering people to lead longer, healthier lives through the transformative power of regenerative medicine.